Toggle Main Menu Toggle Search

Open Access padlockePrints

Ion Mobility QTOF-MS Untargeted Lipidomics of Human Serum Reveals a Metabolic Fingerprint for GNE Myopathy

Lookup NU author(s): Dr Andreas Roos, Dr Oksana Pogoryelova, Dr Sally Spendiff, Professor Hanns Lochmuller

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Abstract

© 2024 by the authors. GNE myopathy, also known as hereditary inclusion body myopathy (HIBM), is a rare genetic muscle disorder marked by a gradual onset of muscle weakness in young adults. GNE myopathy (GNEM) is caused by bi-allelic variants in the UDP-N-acetylglucosamine 2-epimerase (UDP-GlcNAc 2-epimerase)/N-acetylmannosamine kinase (ManNAc kinase) gene (GNE), clinically resulting in the loss of ambulation within 10–20 years from the onset of the initial symptoms. The disease’s mechanism is poorly understood and non-invasive biomarkers are lacking, hindering effective therapy development. Based on the available evidence, we employed a lipidomic approach to study the serum lipid profile of GNE patients. The multivariate statistical analysis revealed a downregulation of carnitines, as well as of lysophosphatidylcholines, in sera samples derived from GNEM patients. Furthermore, we identified lower levels of sphingomyelins and, concomitantly, high levels of ceramides in serum samples from GNEM patients when compared to control samples derived from healthy donors. Moreover, the GNEM serum samples showed the upregulation of Krebs cycle intermediates, in addition to a decrease in oxaloacetic acid. The correlated data gathered in this study can offer a promising diagnostic panel of complex lipids and polar metabolites that can be used in clinic for GNEM in terms of a metabolic fingerprint measurable in a minimally invasive manner.


Publication metadata

Author(s): Manis C, Casula M, Roos A, Hentschel A, Vorgerd M, Pogoryelova O, Derksen A, Spendiff S, Lochmuller H, Caboni P

Publication type: Article

Publication status: Published

Journal: Molecules

Year: 2024

Volume: 29

Issue: 21

Online publication date: 04/11/2024

Acceptance date: 19/10/2024

Date deposited: 19/11/2024

ISSN (electronic): 1420-3049

Publisher: MDPI

URL: https://doi.org/10.3390/molecules29215211

DOI: 10.3390/molecules29215211

Data Access Statement: Data are contained within the article and Supplementary Materials.


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
European Union Horizon 2020 research and innovation programme (EJP RD COFOUND-EJP n°825575)

Share